FIELD: biotechnologies.
SUBSTANCE: composition for treatment of TSLP-associated disorder is described which contains the therapeutically efficient quantity of the named antibody, the method of obtaining of the named antibody, the method of suppression of the immune response at adding of the named antibody, use of the named antibody for obtaining of the medicine.
EFFECT: invention allows to treat TSLP-associated diseases in efficient way.
16 cl, 1 dwg, 9 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODIES AGAINST PD-1 AND THEIR USE | 2018 |
|
RU2788616C2 |
| THYMIC STROMAL LYMPHOPOIETIN RECEPTOR ANTIBODIES | 2007 |
|
RU2486202C2 |
| HUMANISED ANTI-LIGHT ANTIBODIES AND USING THEM | 2010 |
|
RU2542394C2 |
| MOLECULES BINDING TO THYMIC STROMAL LYMPHOPOIETIN (TSLP), AND METHODS OF USING SUCH MOLECULES | 2016 |
|
RU2731644C2 |
| ANTIBODIES AGAINST CD40 AND THEIR USE | 2018 |
|
RU2796413C2 |
| HUMANISED TAU ANTIBODIES IN ALZHEIMER DISEASE | 2015 |
|
RU2730668C2 |
| ANTIBODY IGG WITH AFFINITY BINDING WITH RESPECT TO ANTIGENIC COMPLEX CD3, RECOMBINANT NUCLEIC ACIDS ENCODING ANTIBODY LIGHT AND HEAVY CHAIN, METHOD FOR PREPARING SYSTEM, METHOD FOR PREPARING ANTIBODY, METHOD FOR TREATMENT OF PATIENT | 1999 |
|
RU2244720C2 |
| ANTIBODIES AGAINST CTLA4 AND THEIR USE | 2017 |
|
RU2779312C2 |
| ANTIBODIES AGAINST OX40 AND THEIR USE | 2017 |
|
RU2783314C2 |
| ANTIBODIES AGAINST NEYROPILIN AND METHODS OF THEIR APPLICATION | 2011 |
|
RU2571226C2 |
